| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |